Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

BNTX

BioNTech (BNTX)

BioNTech SE
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BNTX
FechaHoraFuenteTítuloSímboloCompañía
04/03/202515:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
27/02/202506:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
24/02/202505:45GlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025NASDAQ:BNTXBioNTech SE
04/02/202510:15IH Market NewsModerna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s NominationNASDAQ:BNTXBioNTech SE
03/02/202505:45GlobeNewswire Inc.BioNTech Completes Acquisition of BiotheusNASDAQ:BNTXBioNTech SE
14/01/202505:45GlobeNewswire Inc.BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BNTXBioNTech SE
13/11/202416:00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BNTXBioNTech SE
13/11/202405:45GlobeNewswire Inc.BioNTech to Acquire Biotheus to Boost Oncology StrategyNASDAQ:BNTXBioNTech SE
04/11/202405:45GlobeNewswire Inc.BioNTech Announces Third Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
31/10/202406:45GlobeNewswire Inc.BioNTech to Host Innovation Series R&D Day on November 14, 2024NASDAQ:BNTXBioNTech SE
21/10/202405:45GlobeNewswire Inc.BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024NASDAQ:BNTXBioNTech SE
01/10/202405:00GlobeNewswire Inc.BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI DayNASDAQ:BNTXBioNTech SE
20/09/202407:11Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European UnionNASDAQ:BNTXBioNTech SE
17/09/202405:45GlobeNewswire Inc.BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024NASDAQ:BNTXBioNTech SE
05/09/202406:15GlobeNewswire Inc.BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024NASDAQ:BNTXBioNTech SE
22/08/202413:15Business WirePfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 VaccineNASDAQ:BNTXBioNTech SE
16/08/202405:45Business WirePfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of AgeNASDAQ:BNTXBioNTech SE
05/08/202404:59GlobeNewswire Inc.BioNTech Announces Second Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
31/07/202404:55IH Market NewsASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and MoreNASDAQ:BNTXBioNTech SE
30/07/202405:45GlobeNewswire Inc.BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced MelanomaNASDAQ:BNTXBioNTech SE
22/07/202405:45GlobeNewswire Inc.BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024NASDAQ:BNTXBioNTech SE
27/06/202409:30Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European UnionNASDAQ:BNTXBioNTech SE
27/06/202409:30GlobeNewswire Inc.Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union  NASDAQ:BNTXBioNTech SE
24/06/202405:45GlobeNewswire Inc.BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate CancerNASDAQ:BNTXBioNTech SE
01/06/202409:00GlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
29/05/202407:00GlobeNewswire Inc.BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine EcosystemNASDAQ:BNTXBioNTech SE
26/05/202419:00PR Newswire (US)MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnershipNASDAQ:BNTXBioNTech SE
21/05/202405:45GlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024NASDAQ:BNTXBioNTech SE
17/05/202410:15GlobeNewswire Inc.BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024NASDAQ:BNTXBioNTech SE
06/05/202407:09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX